Decitabine and Anti-PD-1 in R/R DLBCL

Clinical trial NCT05816746 · UNKNOWN

Trial details

NCT number: NCT05816746
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma Relapse/Recurrence Extranodal Extension Central Nervous System Lymphoma

Start date: 2023-05-15
Primary completion: 2025-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.